Madan Ajay
- SEC CIK
- 0001807856
No open-market purchases or sales filed in the past year.
Current role at each company
- CRNX Crinetics Pharmaceuticals, Inc.Chief Development Officeras of Mar 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Madan Ajay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Madan AjayChief Development Officer | SSale | +9.00K | $19.88 | +$178.9K | +5.4%177.0K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Madan AjayChief Development Officer | SSale | −13.4K | $17.83 | −$239.1K | −7.2%172.0K after |